YorkBridge Wealth Partners’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-879
Closed -$80K 500
2019
Q2
$80K Sell
879
-264
-23% -$22.3K 0.04% 320
2019
Q1
$98K Buy
1,143
+30
+3% +$2.41K 0.05% 277
2018
Q4
$86K Buy
+1,113
New +$86.6K 0.05% 269
2017
Q2
Sell
-35
Closed -$2K 897
2017
Q1
$2K Hold
35
﹤0.01% 778
2016
Q4
$2K Buy
+35
New +$2.27K ﹤0.01% 768

Other funds holding NVS

YorkBridge Wealth Partners's NVS Position: Q3 2019 in Review

YorkBridge Wealth Partners sold out of Novartis (NVS) in Q3 2019, closing a stake of 879 shares — an estimated $80K sold.

YorkBridge Wealth Partners first reported a position in NVS in Q4 2016 and held it in 5 quarters. The position peaked at $98K in Q1 2019. 1,090 funds tracked by Wall St. Rank hold NVS as of Q3 2019.

  • YorkBridge Wealth Partners reported no remaining Novartis position as of Q3 2019 after selling out during the quarter.
  • YorkBridge Wealth Partners sold 879 Novartis shares in Q3 2019, an estimated $80K.
  • YorkBridge Wealth Partners first reported a position in Novartis in Q4 2016 and held it in 5 quarters.
  • YorkBridge Wealth Partners's Novartis position peaked at $98K in Q1 2019.
  • 1,090 funds tracked by Wall St. Rank held Novartis as of Q3 2019.

Based on YorkBridge Wealth Partners's 13F filing for Q3 2019, filed 21 Oct 2019.